Thu.Dec 15, 2022

article thumbnail

Activist shareholders ask 9 big pharmas to consider whether 'excessive' patenting hurts access

Fierce Pharma

Activist shareholders ask 9 big pharmas to consider whether 'excessive' patenting hurts access. zbecker. Thu, 12/15/2022 - 10:51.

Pharma 299
article thumbnail

Former VA Secretary Teams up With Daughter to Launch Chronic Pain Care Startup

MedCity News

Override provides chronic pain patients with a care team that includes a pain physician, a physical therapist, a psychologist and a coach. The company has received $3.5 million in seed funding and has acquired Take Courage Coaching.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AstraZeneca, Merck hit with 3-month delay for Lynparza's FDA filing in first-line prostate cancer

Fierce Pharma

AstraZeneca, Merck hit with 3-month delay for Lynparza's FDA filing in first-line prostate cancer. kdunleavy. Thu, 12/15/2022 - 09:53.

FDA 298
article thumbnail

Superior HealthPlan Launches Partnership with MedArrive, Brave Health

MedCity News

Through the partnership, Superior’s adult Medicaid population will have access to MedArrive’s home care services. If a MedArrive provider notices that a patient could benefit from behavioral health services, that person can be referred to Brave Health.

Patients 122
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Horizon CEO Walbert in line for major payday after Amgen sale

Fierce Pharma

Horizon CEO Walbert in line for major payday after Amgen sale. esagonowsky. Thu, 12/15/2022 - 08:28.

Sales 278
article thumbnail

2023 Likely To Be a Crucial Year for Pharma—and Insurers

MedCity News

2023 is shaping up to be a crucial year for everyone involved – and affected – by the pharmaceutical industry. It’s likely to be a year of experimentation for payers – and defensiveness for drug makers.

Insurance 117

More Trending

article thumbnail

Dousing Burnout Takes a Combination of the Human and the Digital

MedCity News

Healthcare institutions must make clear their seriousness about employee mental health support and overall wellbeing and take decisive actions to make things better.

article thumbnail

Fierce Pharma Asia—Gracell's CAR-T wows, Takeda puts down $4B on Nimbus' TYK2 inhibitor, Bio Farma strikes Merck deal

Fierce Pharma

Fierce Pharma Asia—Gracell's CAR-T wows, Takeda puts down $4B on Nimbus' TYK2 inhibitor, Bio Farma strikes Merck deal. zbecker. Thu, 12/15/2022 - 20:11.

Pharma 130
article thumbnail

How Should We Transform the Delivery of Women’s Health?

MedCity News

We are approaching a new era for women’s health. This new era will usher in true transformation in both the delivery of care and the financial models that underpin it.

article thumbnail

Partnering for the Patient: Innovation Through Collaboration

Fierce Pharma

Partnering for the Patient: Innovation Through Collaboration. jpiatt. Thu, 12/15/2022 - 13:43.

Patients 147
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Care.ai Deploys Its Virtual Nursing Software in New Mexico Hospital

MedCity News

Lovelace Medical Center in Albuquerque has recently established a virtual nursing program using Care.ai’s technology. The solution enables virtual nurses to handle patient care and administrative tasks that don’t require physical proximity. Lovelace is adopting the technology to mitigate the nurse shortage and burnout crisis.

Medical 113
article thumbnail

NICE backs use of Boehringer’s Ofev in IPF from diagnosis

pharmaphorum

Thousands more UK patients with idiopathic pulmonary fibrosis (IPF) will now be eligible for treatment with Boehringer Ingelheim’s Ofev, following new guidance from health technology assessment agency NICE. Ofev (nintedanib) has been recommended since 2015 for NHS use in IPF patients who have a forced vital capacity (FVC) value of 50% to 80% of normal, but will now be an option for people with less severe disease, i.e. an FVC of more than 80%.

article thumbnail

Price Transparency Compliance Is a Very Different Story for Hospitals Vs. Payers

MedCity News

Payers and providers face different challenges when it comes to compliance. The volume of price transparency data that hospitals must disclose online amounts to about 3 terabytes — compared to the whopping 630 terabytes of data that payers have been tasked with posting.

article thumbnail

Best Healthcare Data Analytics Tools in the Market

Medico Reach

In modern healthcare industry, medical organizations and institutions generates huge data. To extract insights from this massive complex data organizations are turning towards healthcare data analytics tools to leverage the benefits in this regard effectively. These are software applications that analyze the collected information from a range of sources, including but not limited to clinical research, operational activity, patient care programs and financial reports.

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

The Care I Wish Our Parents Had

MedCity News

As a daughter who has been through the wringer a few times, I write today to all health care leaders trying to build a better future.

Biopharma 117
article thumbnail

Eisai and Washington University to develop neurodegenerative disease therapies

Pharmaceutical Technology

Eisai has entered a comprehensive research partnership agreement with Washington University School of Medicine in St Louis, US, to develop potential new therapies for neurodegenerative ailments. Under the deal, the parties intend to develop treatments for diseases including Alzheimer’s and Parkinson’s. The alliance will merge the capabilities of the scientists at Washington University in the basic and clinical research in neurodegenerative ailments, such as dementia, with the wide-ranging expert

article thumbnail

Keva Pharmaceuticals Pvt. Ltd- Openings for Quality Assurance/ Quality Control/ R&D -Apply Now

Pharma Pathway

Keva Pharmaceuticals Pvt. Ltd- Openings for Quality Assurance/ Quality Control/ R&D -Apply Now. Job Description. Keva Pharmaceuticals Pvt. Ltd is looking for some enthusiastic change- makers willing to work for the Nepalese Pharmaceutical Industry. If you identify with the provided details, you are encouraged to look for the position that fits your interests, and send your applications to vacancy@keva.com.np at the earliest.

article thumbnail

The evolving role of social media in healthcare

pharmaphorum

In recent years, social media has evolved into an essential part of pharma operations, for better or worse. Within the life sciences space, traditional ways of leveraging social media include marketing and spreading awareness of a disease or treatment. In addition, many organisations are now also using social media for non-accredited medical education, social listening, and facilitation of networking and best practice sharing.

Media 82
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

European Commission approves first medicine for prurigo nodularis

European Pharmaceutical Review

The European Commission (EC) has expanded the marketing authorisation for Dupixent ® (dupilumab) in the European Union (EU), to treat adults with moderate-to-severe prurigo nodularis (PN) who are candidates for systemic therapy, making it the first and only targeted medicine for the condition in Europe and the US. The EC decision is based on data from two Phase III trials, PRIME and PRIME2 , evaluating the efficacy and safety of Dupixent ® (PRIME n=75; PRIME2 n=78) in 311 adults with uncontrolle

article thumbnail

The Data Quality Imperative: The Critical Importance of Data Quality

Copyright Clearance Center

The post The Data Quality Imperative: The Critical Importance of Data Quality appeared first on Copyright Clearance Center.

98
article thumbnail

Lilly and EVA Pharma to aid affordable insulin access in Africa

European Pharmaceutical Review

At least one million people living with type 1 and type 2 diabetes in low- to middle-income countries (LMICs), mainly Africa, are set to benefit from Eli Lilly and Company and manufacturer EVA Pharmaceutical’s new collaboration delivering a sustainable supply of high-quality, affordable human and analogue insulin to this population. EVA Pharma anticipates beginning distribution of the African-made insulin products within 18 months.

Pharma 79
article thumbnail

Pharma says VPAS clawback jeopardises UK sector

pharmaphorum

A pharma industry organisation has warned that record levels of revenue clawback from the UK government is threatening “footprint, R&D and manufacturing investments” in the country. The Association of the British Pharmaceutical Industry (ABPI) said today that in 2023 manufacturers of branded medicines will have to return almost £3.3 billion (around $4 billion) in revenue to the government – 26.5% of total sales – under the Voluntary Scheme for Branded Medicines Pricing and Access

Pharma 72
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

9 Best Digital Business Card Apps for 2023

Spotio

Are you still handing out physical business cards to prospective customers? You need to get with the times and invest in one of the best digital business card apps! In this article, we’ll explain what digital business cards are, why they’re beneficial to field sellers like you, how to choose the right solution for your needs, and the top digital business card apps on the market in 2023.

article thumbnail

The invisible burden of RSV on older adults

pharmaphorum

As we continue to move beyond the COVID-19 pandemic, we’ve seen many aspects of life returning to normal. The removal of social distancing measures and national and local lockdowns have allowed us to see friends and family once again without fear. However, this has led to increased transmission of other respiratory diseases and, as we’re already seeing, there are now some very real concerns about a lesser-known virus – respiratory syncytial virus, or RSV. 1.

Leads 69
article thumbnail

Sustainable logistics are key to a sustainable future

Clarivate

Logistics is currently one of the bottlenecks to achieving the UN Sustainable Development Goals, but it doesn’t have to be this way. Through careful planning, cooperation among stakeholders and application of emerging technologies, logistics can support the world toward a better, more sustainable future. The demands of modern society on logistics. Logistics is the foundation of global, regional and local supply chains and is key to a well-functioning, modern society.

article thumbnail

Medicines priced under the early access programme in France see prices drop by 16%

Pharmaceutical Technology

France’s temporary authorisation system (autorisation temporaire d’utilisation, ATU) was developed to provide early market access for treatments in therapeutic areas with unmet medical need, limited therapeutic alternatives, or where no authorised alternatives are available. Last year, the French National Authority for Health (HAS) expanded its remit (previously under the control of Agence nationale de sécurité du médicament et des produits de santé [ANSM]) to include early access authorisation

article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

FDA says yes to MedCognetics breast cancer screening AI

pharmaphorum

Digital health company MedCognetics has picked up an FDA approval for QmTRIAGE, its artificial intelligence-powered software for detecting breast cancer in medical images. The company said QmTRIAGE can help alleviate a chronic shortage in radiology services around the world. It cites data estimating there is ten-fold higher demand for radiology services than available capacity, with around half of practitioners “experiencing depression or burnout” due to “unmanageable caseloads

FDA 59
article thumbnail

How one of the world’s most prolific inventors is guiding a plan to tackle all disease

PharmaVoice

Steve Quake, science head at the Chan Zuckerberg Initiative, is leveraging personal experiences and a deep background in R&D to lead an ambitious 100-year plan.

Leads 59
article thumbnail

MinervaX reveals financing to development group B streptococcus vaccine

PharmaTimes

Plans include phase 3 clinical development of novel GBS vaccine and an efficacy evaluation

83
article thumbnail

6 Examples of Successful Sales Strategies for Any Business

Contrarian Sales Techniques

Sales strategy is an important aspect of any business, as it helps to identify and target potential customers, and to effectively communicate the value of a product or service. A well-crafted sales strategy can help a business to increase revenue, improve customer relationships, and build brand loyalty. There are many different sales strategies that businesses can use, depending on their goals, target market, and resources.

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.